Adjuvant aromatase inhibitors in patients with PIK3CA mutation early breast cancer

被引：0
|
作者：
Reinhardt, K. [1 ]
Vetter, M. [2 ]
Kaufhold, S. [1 ]
Kantelhardt, E. [2 ]
Thomssen, C. [2 ]
机构：
[1] Martin Luther Univ Halle Wittenberg, Dept Gynaecol, Halle, Saale, Germany
[2] UKH Univ Klinikum Halle Saale, Dept Gynaecol, Halle, Saale, Germany
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.477
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
280P
引用
收藏
页码：S296 / S296
页数：1
相关论文
共 50 条
  • [31] Liquid biopsy for PIK3Ca mutation in cervical cancer
    Chung, T. K. H.
    Cheung, T. H.
    Yim, S. F.
    Wong, R. R. Y.
    Elias, K.
    Smith, D.
    Berkowitz, R. S.
    Wong, Y. F.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 489 - 489
  • [32] Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition
    Elena López-Knowles
    Corrinne V Segal
    Qiong Gao
    Isaac Garcia-Murillas
    Nicholas C Turner
    Ian Smith
    Lesley-Ann Martin
    Mitch Dowsett
    [J]. Breast Cancer Research, 16
  • [33] PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
    Loi, Sherene
    Michiels, Stefan
    Baselga, Jose
    Bartlett, John M. S.
    Singhal, Sandeep K.
    Sabine, Vicky S.
    Sims, Andrew H.
    Sahmoud, Tarek
    Dixon, J. Michael
    Piccart, Martine J.
    Sotiriou, Christos
    [J]. PLOS ONE, 2013, 8 (01):
  • [34] Prevalence and spectrum of PIK3CA mutations in Indian breast cancer patients
    Katara, Rahul
    Bhardwaj, Tina
    Rawat, Monika
    Sharma, Deepak K.
    Kumar, Vipin
    Sharma, Shivani
    Dagar, Vaishali
    Kumar, Pawan
    Mohanty, Sambit K.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [35] Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients
    Allouchery, Violette
    Perdrix, Anne
    Calbrix, Celine
    Berghian, Anca
    Lequesne, Justine
    Fontanilles, Maxime
    Leheurteur, Marianne
    Etancelin, Pascaline
    Sarafan-Vasseur, Nasrin
    Di Fiore, Frederic
    Clatot, Florian
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] Hotspot mutations in PIK3CA are predictive for treatment outcome on aromatase inhibitors but not for tamoxifen
    Ramirez, Ardila D. E.
    Helmijr, J. C.
    Lurkin, I.
    Look, M.
    Ruigrok-Ritstier, K.
    Simon, I.
    Van Laere, S.
    Sweep, F.
    Span, P.
    Linn, S.
    Foekens, J.
    Sleijfer, S.
    Berns, E. M. J. J.
    Jansen, M. P. H. M.
    [J]. CANCER RESEARCH, 2012, 72
  • [37] Plasma PIK3CA Mutation Testing in Advanced Breast Cancer Patients for Personalized Medicine: A Value Proposition
    Ferreira-Gonzalez, Andrea
    [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (05): : 1076 - 1089
  • [38] Frequent mutation of the PIK3CA gene in ovarian and breast cancers
    Levine, DA
    Bogomolniy, F
    Yee, CJ
    Lash, A
    Barakat, RR
    Borgen, PI
    Boyd, J
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (08) : 2875 - 2878
  • [39] PIK3CA mutation prevalence in hormone receptor positive breast cancer patients in United Arab Emirates
    Azribi, Fathi
    Hourani, Mohammad
    Magdub, Sulaman
    Alawadhi, Aydah
    Yousif, Ali
    Dawoud, Emad
    Al Qawasmeh, Khaled
    Al Ameri, Mouza
    Trad, Diaeddine
    Bennini, Nouri
    Ahmed, Mohamed
    Ansari, Jawaher
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [40] Assessment of clonal and subclonal PIK3CA mutations in patients with breast cancer
    Udhane, Sameer S.
    Alyaqoub, Fadel
    Noel, Pawan
    Kemkes, Ariane
    Flannery, Cynthia A.
    Innis, Paige E.
    Hall, David W.
    Thakkar, Snehal G.
    Basu, Gargi
    O'Shaughnessy, Joyce
    [J]. CANCER RESEARCH, 2024, 84 (03)
12345